Table 2.
Treatment | Stage | No. of Embryos/Larvae | Minimum No. of PGCs | Maximum No. of PGCs | Mean | SD | p |
---|---|---|---|---|---|---|---|
Control | Neurula | 11 | 15 | 52 | 32.00 | 12.88 | 0.0004467 |
22 dpf | 8 | 51 | 92 | 71.88 | 16.78 | ||
CRISPR/Cas9 | Neurula | 16 | 0 | 13 | 6.00 | 4.84 | 0.008104 |
22 dpf | 11 | 0 | 5 | 1.18 | 2.04 | ||
Dnd1-MO | Neurula | 20 | 0 | 16 | 3.30 | 5.59 | 0.7032 |
22 dpf | 9 | 0 | 12 | 5.56 | 4.77 | ||
UV240 | Neurula | 20 | 0 | 16 | 6.05 | 5.96 | 0.3819 |
22 dpf | 19 | 0 | 18 | 4.89 | 6.13 |
Wilcoxon test.